T1	Participants 67 116	patients with advanced non-small-cell lung cancer
T2	Participants 311 345	patients with advanced lung cancer
T3	Participants 490 554	Twelve patients with advanced non-small-cell lung cancer (NSCLC)
T4	Participants 820 871	Thirteen NSCLC patients and eleven healthy subjects
